Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Celldex Therapeutics, Inc. | 30,796 | reported | 04 Dec 2025 | tx 18+412,142−54,655 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 Dec 2025 | SALE | Celldex Therapeutics, Inc. | 4,166 | 29.10 USD | |
| 13 Aug 2025 | SALE | Celldex Therapeutics, Inc. | 341 | 23.95 USD | |
| 13 Aug 2025 | SALE | Celldex Therapeutics, Inc. | 430 | 25.42 USD | |
| 05 Jun 2025 | GRANT_AWARD | Celldex Therapeutics, Inc. | 75,000 | 0.00 USD | deriv |
| 13 Jun 2024 | GRANT_AWARD | Celldex Therapeutics, Inc. | 75,000 | 0.00 USD | deriv |
| 05 Jun 2024 | EXERCISE | Celldex Therapeutics, Inc. | 9,540 | 10.38 USD | |
| 05 Jun 2024 | EXERCISE | Celldex Therapeutics, Inc. | 9,540 | 0.00 USD | deriv |
| 03 Jun 2024 | EXERCISE | Celldex Therapeutics, Inc. | 8,006 | 10.38 USD | |
| 03 Jun 2024 | SALE | Celldex Therapeutics, Inc. | 8,006 | 33.60 USD | |
| 03 Jun 2024 | EXERCISE | Celldex Therapeutics, Inc. | 8,006 | 0.00 USD | deriv |
| 13 Feb 2024 | EXERCISE | Celldex Therapeutics, Inc. | 4,166 | 9.02 USD | |
| 13 Feb 2024 | EXERCISE | Celldex Therapeutics, Inc. | 20,000 | 2.78 USD | |
| 13 Feb 2024 | EXERCISE | Celldex Therapeutics, Inc. | 20,000 | 0.00 USD | deriv |
| 13 Feb 2024 | EXERCISE | Celldex Therapeutics, Inc. | 4,166 | 0.00 USD | deriv |
| 15 Jun 2023 | GRANT_AWARD | Celldex Therapeutics, Inc. | 74,000 | 0.00 USD | deriv |
| 16 Jun 2022 | GRANT_AWARD | Celldex Therapeutics, Inc. | 73,000 | 0.00 USD | deriv |
| 11 Aug 2021 | PURCHASE | Celldex Therapeutics, Inc. | 430 | 46.28 USD | |
| 17 Jun 2021 | GRANT_AWARD | Celldex Therapeutics, Inc. | 73,000 | 0.00 USD | deriv |